. 2018 Jan 31;32(3):206–216. doi: 10.1007/s12149-018-1236-1

Table 3.

Characteristics of 16 volunteers and patients examined both by PiB and by FPFBF-2

Test subject	Age	Sex	Clinical diagnosis	MMSE score	PiB		FPYBF-2
Test subject	Age	Sex	Clinical diagnosis	MMSE score		SUVR		SUVR
#1	39	M	Healthy volunteer	25	WNL	0.961	WNL	0.895
#2	41	M	Healthy volunteer^a	30	WNL	1.045	WNL	1.001
#3	51	M	Healthy volunteer	30	WNL	1.214	WNL	1.087
#4	54	M	Healthy volunteer	30	WNL	1.100	WNL	1.064
#5	70	F	Healthy volunteer	28	WNL	1.079	WNL	1.049
#6	72	M	MCI	24	High	2.285	High	1.374
#7	76	M	MCI	25	High	1.757	High	1.249
#8	82	M	MCI	24	WNL	1.057	WNL	0.862
#9	56	M	Early AD	26	High	1.831	High	1.326
#10	73	F	Early AD	21	High	2.090	High	1.502
#11	76	M	Early AD^c	19	High	1.756	High	1.322
#12	78	F	Early AD	24	WNL	1.253	High	1.246
#13	78	F	Moderate AD^b	15	High	2.230	High	1.568
#14	60	F	Other dementia (amyloid angiopathy)	30	WNL	0.932	WNL	0.892
#15	73	F	Other dementia (FTD)	19	WNL	1.238	WNL	1.060
#16	82	M	Other dementia (unknown)	23	WNL	1.134	WNL	0.989
Total	66.3 ± 14.2		24.2 + 44.4		1.435 ± 0.474		1.155 ± 0.219

MCI mild cognitive insufficiency, MMSE mini mental state examination, AD Alzheimer’s disease, SUVR standardized uptake value ratio, FTD fronto temporal dementia, WNL within normal limit

^a Case B, ^b Case C, ^c Case D in Fig. 6